浆母细胞性淋巴瘤
医学
危险分层
淋巴瘤
内科学
重症监护医学
作者
Andres Ramirez‐Gamero,Humberto Martínez‐Cordero,Brady Beltrán,Jorge A. Florindez,Luis Malpica,Jorge J. Castillo
摘要
Combination chemotherapy regimens, such as EPOCH, are recommended. The addition of bortezomib, lenalidomide, or daratumumab might improve outcomes. Including PBL patients and their participation in prospective clinical trials is warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI